Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Xenetic Biosciences Operating Margin 2013-2019 | XBIO

Current and historical operating margin for Xenetic Biosciences (XBIO) over the last 10 years. The current operating profit margin for Xenetic Biosciences as of December 31, 2019 is 0.00%.
  
Xenetic Biosciences Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.003B $0.000B
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications. Additionally, Xenetic is leveraging PolyXen(TM), its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. PolyXen(TM) has demonstrated its ability to improve the half-life and other pharmacological properties of next-generation biologic drugs. The Company has an exclusive license agreement with Takeda Pharmaceuticals Co. Ltd. in the field of coagulation disorders and expects to earn royalty payments under this agreement.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $55.895B 32.33
Takeda Pharmaceutical (TAK) Japan $47.859B 8.39
Astellas Pharma (ALPMY) Japan $28.786B 14.38
Eisai (ESALY) Japan $21.373B 39.82
UCB SA (UCBJF) Belgium $16.930B 0.00
Grifols, S.A (GRFS) Spain $13.847B 17.21
Merck (MKGAF) Germany $13.479B 17.68
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $7.988B 221.92
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.606B 31.30
Ionis Pharmaceuticals (IONS) United States $6.582B 19.95
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.721B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.599B 6.83
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.595B 0.00
IPSEN SA ADR (IPSEY) France $4.511B 0.00
United Therapeutics (UTHR) United States $4.161B 0.00
Evotec AG (EVTCY) Germany $3.422B 55.18
Hypermarcas (HYPMY) Brazil $3.207B 9.75
Nektar Therapeutics (NKTR) United States $3.169B 0.00
FibroGen (FGEN) United States $3.058B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.925B 54.28
PTC Therapeutics (PTCT) United States $2.794B 0.00
ChemoCentryx (CCXI) United States $2.477B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.341B 9.47
Xencor (XNCR) United States $1.701B 69.49
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.629B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.596B 19.40
Sage Therapeutics (SAGE) United States $1.491B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.456B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.409B 38.54
Corcept Therapeutics (CORT) United States $1.363B 15.24
Karyopharm Therapeutics (KPTI) United States $1.259B 0.00
USANA Health Sciences (USNA) United States $1.245B 13.07
Zogenix (ZGNX) United States $1.122B 0.00
Heron Therapeutics (HRTX) United States $1.061B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.041B 14.50
Enanta Pharmaceuticals (ENTA) United States $1.025B 31.75
Akebia Therapeutics (AKBA) United States $0.984B 0.00
Esperion Therapeutics (ESPR) United States $0.867B 0.00
Endo (ENDP) Ireland $0.839B 1.55
CLINIGEN GP (CLIGF) United Kingdom $0.838B 0.00
Tilray (TLRY) Canada $0.716B 0.00
Aerie Pharmaceuticals (AERI) United States $0.627B 0.00
Molecular Templates (MTEM) United States $0.607B 0.00
Radius Health (RDUS) United States $0.601B 0.00
Translate Bio (TBIO) United States $0.598B 0.00
ImmunoGen (IMGN) United States $0.594B 0.00
Collegium Pharmaceutical (COLL) United States $0.560B 0.00
Portola Pharmaceuticals (PTLA) United States $0.557B 0.00
Indivior (INVVY) United States $0.427B 2.54
BioSpecifics Technologies Corp (BSTC) United States $0.415B 17.04
Catalyst Pharmaceuticals (CPRX) United States $0.398B 13.28
Siga Technologies (SIGA) United States $0.388B 0.00
Innate Pharma SA (IPHYF) France $0.385B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.380B 0.00
Ardelyx (ARDX) United States $0.374B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.361B 0.00
Organogenesis Holdings (ORGO) United States $0.340B 0.00
Trillium Therapeutics (TRIL) Canada $0.332B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.308B 0.00
DURECT (DRRX) United States $0.304B 0.00
Flexion Therapeutics (FLXN) United States $0.303B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.297B 0.00
Harpoon Therapeutics (HARP) United States $0.289B 0.00
TherapeuticsMD (TXMD) United States $0.288B 0.00
Calithera Biosciences (CALA) United States $0.287B 0.00
Lannett Co Inc (LCI) United States $0.280B 4.51
Oasmia Pharmaceutical AB (OASMY) Sweden $0.279B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.267B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.263B 0.00
Concert Pharmaceuticals (CNCE) United States $0.262B 0.00
Ocular Therapeutix (OCUL) United States $0.260B 0.00
OptiNose (OPTN) United States $0.206B 0.00
Rafael Holdings (RFL) United States $0.203B 0.00
CASI Pharmaceuticals (CASI) United States $0.202B 0.00
Recro Pharma (REPH) United States $0.191B 0.00
MEI Pharma (MEIP) United States $0.171B 0.00
Jounce Therapeutics (JNCE) United States $0.162B 2.91
Nature's Sunshine Products (NATR) United States $0.158B 19.83
PROFOUND MEDICL (PROF) Canada $0.157B 0.00
Taiwan Liposome (TLC) Taiwan $0.137B 0.00
KalVista Pharmaceuticals (KALV) United States $0.137B 0.00
VAXART, INC (VXRT) United States $0.125B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.118B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.114B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.106B 0.00
Redhill Biopharma (RDHL) Israel $0.099B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.095B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.088B 0.00
IMV INC (IMV) Canada $0.088B 0.00
Champions Oncology (CSBR) United States $0.088B 0.00
SCYNEXIS (SCYX) United States $0.076B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.076B 0.00
Aquestive Therapeutics (AQST) United States $0.074B 0.00
Xeris Pharmaceuticals (XERS) United States $0.073B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.073B 0.00
Hemispherx BioPharma (AIM) United States $0.073B 0.00
Biomerica (BMRA) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.068B 0.00
Otonomy (OTIC) United States $0.061B 0.00
CV Sciences (CVSI) United States $0.058B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.055B 17.29
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
Sundial Growers (SNDL) Canada $0.054B 0.00
Nivalis Therapeutics (ALPN) United States $0.054B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.053B 0.00
PharmAthene (ALT) United States $0.049B 0.00
Infinity Pharmaceuticals (INFI) United States $0.048B 0.00
GTx (ONCT) United States $0.045B 0.00
Natural Alternatives (NAII) United States $0.043B 19.69
Aclaris Therapeutics (ACRS) United States $0.043B 0.00
MediWound (MDWD) Israel $0.043B 0.00
Onconova Therapeutics (ONTX) United States $0.042B 0.00
PolarityTE (PTE) United States $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.041B 136.86
Forward Pharma (FWP) Denmark $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.037B 0.00
IsoRay (ISR) United States $0.036B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.035B 0.00
AgeX Therapeutics (AGE) United States $0.035B 0.00
Heat Biologics (HTBX) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.028B 0.00
Mannatechorporated (MTEX) United States $0.026B 8.04
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.024B 0.00
Lipocine (LPCN) United States $0.023B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Novan (NOVN) United States $0.022B 0.00
Cardiome Pharma (CORV) Canada $0.021B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.021B 0.00
India Globalization Capital (IGC) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
China SXT Pharmaceuticals (SXTC) China $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
Vical (BBI) United States $0.012B 0.00
KemPharm (KMPH) United States $0.011B 0.00
Can-Fite Biopharma (CANF) Israel $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.001B 0.00